 Updated News | New Novartis drug shows potential in heart failure Fox News Novartis, long a major player in cardiovascular medicine, is looking to LCZ696 as one of two new treatments for heart failure that could revive its fortunes at a time when top-selling blood pressure pill Diovan is facing generic competition. The Swiss ... Efficacy of LCZ696 in patients with heart failure and preserved ejection fraction Phase II study of Novartis' drug LCZ696 reduces key predictor of morbidity ... Novartis Drug Shows Promise in Heart Failure |
